GSK Investigational Site

Markham, Ontario L6B 1A1

0 studies enrolling now · 6 studies all time

What they study most

Dermatitis, Atopic, Neoplasms, Prostate, Psoriasis

Studies at this site

• Long-Term Study (AtDvance) to Evaluate GSK1070806 in Atopic Dermatitis. — Stopped early
• A Dose Finding Study to Investigate the Safety and Effectiveness of GSK1070806 in Adult Participants With Moderate to Severe Atopic Dermatitis — Stopped early
• Efficacy and Safety Study of Mepolizumab in Subjects With Moderate to Severe Atopic Dermatitis — Stopped early
• A Dose-Finding Study of GSK2894512 Cream in Subjects With Atopic Dermatitis (AD) — Completed
• A Dose-Finding Study of GSK2894512 Cream in Subjects With Plaque Psoriasis — Completed
• "REDUCE" - A Clinical Research Study To Reduce The Incidence Of Prostate Cancer In Men Who Are At Increased Risk — Completed